Biden Falls Short on U.S. Vaccine ‘Arsenal’ Pledge, Experts Say
Congress appropriated $16 billion to ramp up Covid-19 countermeasures, but a new report found that the Biden administration had spent very little of it on expanding vaccine manufacturing capacity.
